ProShares Ultra Bloomberg Natural Gas

United States Natural Gas

MicroSectors Gold Miners 3X Leveraged ETN

Altimmune Inc. Common Stock

Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily Gold Miners Bull 3X ETF

ProShares Ultra Silver

Global X Silver Miners ETF

Direxion Daily FTSE China Bull 3X ETF

VanEck Vectors Junior Gold Miners ETF

ProShares UltraShort Bloomberg Natrl Gas

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily Gold Miners Bear 3X ETF

ProShares UltraShort Silver

Bank Of Montreal

GraniteShares 2x Long AMZN Daily ETF

Direxion Daily 20+ Yr Trsy Bull 3X ETF

ProShares UltraPro QQQ

Direxion Daily Technology Bull 3X ETF

BloomZ Inc. Ordinary Shares

Siyata Mobile Inc. Common Shares

Edible Garden AG Incorporated Common Stock

TNL Mediagene Ordinary Shares

Neuraxis Inc. Common Stock

Eyenovia Inc. Common Stock

Click Holdings Limited Ordinary Share

D-Wave Quantum Inc. Common Shares

PicoCELA Inc. American Depositary Shares

Warby Parker Inc. Class A Common Stock

Protagenic Therapeutics Inc. Common Stock

NWTN Inc. Class B Ordinary Shares

Classover Holdings Inc. Class B Common Stock

Theriva Biologics Inc. Common Stock

Brainstorm Cell Therapeutics Inc. Common Stock

Carter's Inc. Common Stock

Treasure Global Inc. Common Stock

Luminar Technologies Inc.  Class A Common Stock

ASP Isotopes Inc. Common Stock

AgEagle Aerial Systems Inc. Common Stock

Click here to get full coverage on Eyenovia Slashes Cash Burn 70% While Racing Toward Major FDA Filing and Merger Deal - Stock Titan

Eyenovia Slashes Cash Burn 70% While Racing Toward Major FDA Filing and Merger Deal  Stock Titan

Eyenovia Slashes Cash Burn 70% While Racing Toward Major FDA Filing and Merger Deal - Stock Titan

Click here to get full coverage on Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews

Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO...  RTTNews

Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews

Click here to get full coverage on Eyenovia Provides Updates on Potential Merger with Betaliq - GlobeNewswire

Eyenovia Provides Updates on Potential Merger with Betaliq  GlobeNewswire

Eyenovia Provides Updates on Potential Merger with Betaliq - GlobeNewswire

Click here to get full coverage on Eyenovia (EYEN) Pursues Merger with Betaliq and Advances Optejet Device | EYEN Stock News - GuruFocus

Eyenovia (EYEN) Pursues Merger with Betaliq and Advances Optejet Device | EYEN Stock News  GuruFocus

Eyenovia (EYEN) Pursues Merger with Betaliq and Advances Optejet Device | EYEN Stock News - GuruFocus

Click here to get full coverage on Eyenovia Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Eyenovia Inc reports results for the quarter ended March 31 - Earnings Summary  TradingView

Eyenovia Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Click here to get full coverage on Here's Why Eyenovia (EYEN) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance

Here's Why Eyenovia (EYEN) Is a Great 'Buy the Bottom' Stock Now  Yahoo Finance

Here's Why Eyenovia (EYEN) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance

Click here to get full coverage on Revolutionary Eye Drug Device Passes Critical Tests: Eyenovia's Game-Changing Innovation - Stock Titan

Revolutionary Eye Drug Device Passes Critical Tests: Eyenovia's Game-Changing Innovation  Stock Titan

Revolutionary Eye Drug Device Passes Critical Tests: Eyenovia's Game-Changing Innovation - Stock Titan

Click here to get full coverage on Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results | EYEN Stock News - GuruFocus

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results | EYEN Stock News  GuruFocus

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results | EYEN Stock News - GuruFocus

Click here to get full coverage on Eyenovia Announces 1-for-80 Reverse Stock Split - GlobeNewswire

Eyenovia Announces 1-for-80 Reverse Stock Split  GlobeNewswire

Eyenovia Announces 1-for-80 Reverse Stock Split - GlobeNewswire

Click here to get full coverage on Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewswire

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq  GlobeNewswire

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewswire

Click here to get full coverage on EYEN - Eyenovia Inc Latest Stock News & Market Updates - Stock Titan

EYEN - Eyenovia Inc Latest Stock News & Market Updates  Stock Titan

EYEN - Eyenovia Inc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - GlobeNewswire

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)  GlobeNewswire

Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - GlobeNewswire

Click here to get full coverage on Eyenovia Escapes Delisting Threat: What's Next for the Optejet Developer? - Stock Titan

Eyenovia Escapes Delisting Threat: What's Next for the Optejet Developer?  Stock Titan

Eyenovia Escapes Delisting Threat: What's Next for the Optejet Developer? - Stock Titan

Click here to get full coverage on Eyenovia Announces Leading Proxy Advisory Firms, ISS and - GlobeNewswire

Eyenovia Announces Leading Proxy Advisory Firms, ISS and  GlobeNewswire

Eyenovia Announces Leading Proxy Advisory Firms, ISS and - GlobeNewswire

Click here to get full coverage on Strategic Merger Alert: Eyenovia and Betaliq Join Forces to Revolutionize Eye Care Delivery - Stock Titan

Strategic Merger Alert: Eyenovia and Betaliq Join Forces to Revolutionize Eye Care Delivery  Stock Titan

Strategic Merger Alert: Eyenovia and Betaliq Join Forces to Revolutionize Eye Care Delivery - Stock Titan

Click here to get full coverage on Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - GlobeNewswire

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering  GlobeNewswire

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - GlobeNewswire

Click here to get full coverage on Eyenovia Explores Strategic Alternatives, Accelerates Optejet Device Development Plans - Stock Titan

Eyenovia Explores Strategic Alternatives, Accelerates Optejet Device Development Plans  Stock Titan

Eyenovia Explores Strategic Alternatives, Accelerates Optejet Device Development Plans - Stock Titan

Click here to get full coverage on Major Shake-up at Eyenovia: Massive 80:1 Share Consolidation Coming February - Stock Titan

Major Shake-up at Eyenovia: Massive 80:1 Share Consolidation Coming February  Stock Titan

Major Shake-up at Eyenovia: Massive 80:1 Share Consolidation Coming February - Stock Titan

Click here to get full coverage on Can This Biotech's Debt Restructuring Lead to a Strategic Sale? - Stock Titan

Can This Biotech's Debt Restructuring Lead to a Strategic Sale?  Stock Titan

Can This Biotech's Debt Restructuring Lead to a Strategic Sale? - Stock Titan

Click here to get full coverage on Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - GlobeNewswire

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device  GlobeNewswire

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - GlobeNewswire

Click here to get full coverage on Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewswire

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements  GlobeNewswire

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewswire

Click here to get full coverage on Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives - GlobeNewswire

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives  GlobeNewswire

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives - GlobeNewswire

Click here to get full coverage on Eyenovia stock falls on reverse merger plans (EYEN:NASDAQ) - Seeking Alpha

Eyenovia stock falls on reverse merger plans (EYEN:NASDAQ)  Seeking Alpha

Eyenovia stock falls on reverse merger plans (EYEN:NASDAQ) - Seeking Alpha

Click here to get full coverage on Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - GlobeNewswire

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives  GlobeNewswire

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - GlobeNewswire

Click here to get full coverage on Eyenovia Provides Update on Phase 3 CHAPERONE Study - GlobeNewswire

Eyenovia Provides Update on Phase 3 CHAPERONE Study  GlobeNewswire

Eyenovia Provides Update on Phase 3 CHAPERONE Study - GlobeNewswire

Click here to get full coverage on Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States - PR Newswire

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States  PR Newswire

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States - PR Newswire

Click here to get full coverage on Eyenovia Stock Tumbles on Termination of Phase III Myopia Study - Yahoo Finance

Eyenovia Stock Tumbles on Termination of Phase III Myopia Study  Yahoo Finance

Eyenovia Stock Tumbles on Termination of Phase III Myopia Study - Yahoo Finance

Click here to get full coverage on Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline - Yahoo Finance

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline  Yahoo Finance

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline - Yahoo Finance

Click here to get full coverage on Eyenovia faces Nasdaq delisting over low stock price - Investing.com

Eyenovia faces Nasdaq delisting over low stock price  Investing.com

Eyenovia faces Nasdaq delisting over low stock price - Investing.com

Click here to get full coverage on Eyenovia Delays Q1 2025 10-Q Filing - TipRanks

Eyenovia Delays Q1 2025 10-Q Filing  TipRanks

Eyenovia Delays Q1 2025 10-Q Filing - TipRanks

Click here to get full coverage on Eyenovia Provides Update on Restructuring Efforts - GlobeNewswire

Eyenovia Provides Update on Restructuring Efforts  GlobeNewswire

Eyenovia Provides Update on Restructuring Efforts - GlobeNewswire

Click here to get full coverage on Eyenovia Announces Pricing of $5.14 Million Public Offering - GlobeNewswire

Eyenovia Announces Pricing of $5.14 Million Public Offering  GlobeNewswire

Eyenovia Announces Pricing of $5.14 Million Public Offering - GlobeNewswire

Click here to get full coverage on Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery - GlobeNewswire

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery  GlobeNewswire

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery - GlobeNewswire

Click here to get full coverage on Eyenovia Inc expected to post a loss of $7.20 a share - Earnings Preview - TradingView

Eyenovia Inc expected to post a loss of $7.20 a share - Earnings Preview  TradingView

Eyenovia Inc expected to post a loss of $7.20 a share - Earnings Preview - TradingView

Click here to get full coverage on Eyenovia to end eye drug study, cut 50% of its workforce - Reuters

Eyenovia to end eye drug study, cut 50% of its workforce  Reuters

Eyenovia to end eye drug study, cut 50% of its workforce - Reuters

Click here to get full coverage on Eyenovia faces Nasdaq delisting over share price dip - Investing.com

Eyenovia faces Nasdaq delisting over share price dip  Investing.com

Eyenovia faces Nasdaq delisting over share price dip - Investing.com

Click here to get full coverage on Eyenovia Inc reports results for the quarter ended December 31 - Earnings Summary - TradingView

Eyenovia Inc reports results for the quarter ended December 31 - Earnings Summary  TradingView

Eyenovia Inc reports results for the quarter ended December 31 - Earnings Summary - TradingView

Click here to get full coverage on Eyenovia Faces Nasdaq Delisting Over Equity Shortfall - Investing.com

Eyenovia Faces Nasdaq Delisting Over Equity Shortfall  Investing.com

Eyenovia Faces Nasdaq Delisting Over Equity Shortfall - Investing.com

Click here to get full coverage on Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet® - GlobeNewswire

Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet®  GlobeNewswire

Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet® - GlobeNewswire

Click here to get full coverage on Liège Waffles, A Belgian Delicacy, Coming To New Cherry Hill Restaurant - Patch

Liège Waffles, A Belgian Delicacy, Coming To New Cherry Hill Restaurant  Patch

Liège Waffles, A Belgian Delicacy, Coming To New Cherry Hill Restaurant - Patch

Click here to get full coverage on Eyenovia regains Nasdaq compliance, eyes strategic options - Investing.com

Eyenovia regains Nasdaq compliance, eyes strategic options  Investing.com

Eyenovia regains Nasdaq compliance, eyes strategic options - Investing.com

Click here to get full coverage on Eyenovia Shares Drop 14% Amid Betaliq Merger Talks - GuruFocus

Eyenovia Shares Drop 14% Amid Betaliq Merger Talks  GuruFocus

Eyenovia Shares Drop 14% Amid Betaliq Merger Talks - GuruFocus

Click here to get full coverage on Eyenovia & SGN Nanopharma Announce Collaboration Agreement - GlobeNewswire

Eyenovia & SGN Nanopharma Announce Collaboration Agreement  GlobeNewswire

Eyenovia & SGN Nanopharma Announce Collaboration Agreement - GlobeNewswire

Click here to get full coverage on Eyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On? - Benzinga

Eyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On?  Benzinga

Eyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On? - Benzinga

Click here to get full coverage on Eyenovia (EYEN) Down 18% on Disappointing Corporate Update - Nasdaq

Eyenovia (EYEN) Down 18% on Disappointing Corporate Update  Nasdaq

Eyenovia (EYEN) Down 18% on Disappointing Corporate Update - Nasdaq

Click here to get full coverage on Eyen Center condemns US deliberate targeting of populated zones - وكالة الانباء اليمنية سبأ

Eyen Center condemns US deliberate targeting of populated zones  وكالة الانباء اليمنية سبأ

Eyen Center condemns US deliberate targeting of populated zones - وكالة الانباء اليمنية سبأ

Click here to get full coverage on Therese Jeanne (Hamme) Eyen Obituary - The Daily Jeffersonian

Therese Jeanne (Hamme) Eyen Obituary  The Daily Jeffersonian

Therese Jeanne (Hamme) Eyen Obituary - The Daily Jeffersonian

Click here to get full coverage on EYEN Stock Price and Chart — NASDAQ:EYEN - TradingView

EYEN Stock Price and Chart — NASDAQ:EYEN  TradingView

EYEN Stock Price and Chart — NASDAQ:EYEN - TradingView

Click here to get full coverage on Eyenovia Announces Closing of $27.3 Million Initial Public Offering - GlobeNewswire

Eyenovia Announces Closing of $27.3 Million Initial Public Offering  GlobeNewswire

Eyenovia Announces Closing of $27.3 Million Initial Public Offering - GlobeNewswire

Click here to get full coverage on Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery - PR Newswire

Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery  PR Newswire

Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery - PR Newswire

Click here to get full coverage on My second chance at life: Inside the school where refugee girls dare to dream again - Daily Nation

My second chance at life: Inside the school where refugee girls dare to dream again  Daily Nation

My second chance at life: Inside the school where refugee girls dare to dream again - Daily Nation

Click here to get full coverage on Delta: Faith based organisations exempted as ALGON authorizes Kenneth George, Peter Eyen to print, manage all mobile stickers across 25 LGAs - Fresh Angle

Delta: Faith based organisations exempted as ALGON authorizes Kenneth George, Peter Eyen to print, manage all mobile stickers across 25 LGAs  Fresh Angle

Delta: Faith based organisations exempted as ALGON authorizes Kenneth George, Peter Eyen to print, manage all mobile stickers across 25 LGAs - Fresh Angle

Click here to get full coverage on Eyenovia updates on late-stage program for presbyopia therapy (NASDAQ:EYEN) - Seeking Alpha

Eyenovia updates on late-stage program for presbyopia therapy (NASDAQ:EYEN)  Seeking Alpha

Eyenovia updates on late-stage program for presbyopia therapy (NASDAQ:EYEN) - Seeking Alpha

Click here to get full coverage on Gov. Udom Emmanuel fires Chief of Staff Inyang-eyen - PM News Nigeria

Gov. Udom Emmanuel fires Chief of Staff Inyang-eyen  PM News Nigeria

Eyenovia Inc (EYEN)

Price Chart

Key Statistics

Technicals

About EYEN

Latest News

Eyenovia Slashes Cash Burn 70% While Racing Toward Major FDA Filing and Merger Deal - Stock Titan

Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews

Eyenovia Provides Updates on Potential Merger with Betaliq - GlobeNewswire

Advanced Charts

Top Gainers

Top Losers